SCOPUS 정보 검색 플랫폼

Blood

Volumn 107, Issue 6, 2006, Pages 2409-2414

IL-2 administration increases CD4+CD25hi Foxp3 + regulatory T cells in cancer patients

(2) Ahmadzadeh, Mojgan a Rosenberg, Steven A a

a NATIONAL CANCER INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; RECOMBINANT INTERLEUKIN 2; TRANSCRIPTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CANCER PATIENT; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVITY; CELL COUNT; CELL FUNCTION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CANCER; LYMPHOCYTOPENIA; MALE; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33644784733 PISSN: 00064971 EISSN: 00064971 Source Type: Journal
DOI: 10.1182/blood-2005-06-2399 Document Type: Article

Times cited : (550)

References (26)

1
- 0017199306
- Selective in vitro growth of T lymphocytes from normal human bone marrows
- Morgan DA, Ruscetti FW, Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 1976;193:1007-1008.
- (1976) Science , vol.193 , pp. 1007-1008
- Morgan, D.A.¹ Ruscetti, F.W.² Gallo, R.³

2
- 0028266553
- Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2
- Rosenberg SA, Yang JC, Topalian SL, et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. J Am Med Assoc. 1994;271:907-913.
- (1994) J Am Med Assoc , vol.271 , pp. 907-913
- Rosenberg, S.A.¹ Yang, J.C.² Topalian, S.L.³

3
- 4544241811
- Tolerance, not immunity, crucially depends on IL-2
- Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol. 2004;4:665-674.
- (2004) Nat Rev Immunol , vol.4 , pp. 665-674
- Malek, T.R.¹ Bayer, A.L.²

4
- 14744268262
- + T regulatory cells, immunotherapy of cancer, and interleukin-2
- + T regulatory cells, immunotherapy of cancer, and interleukin-2. J Immunother. 2005;28:120-128.
- (2005) J Immunother , vol.28 , pp. 120-128
- Antony, P.A.¹ Restifo, N.P.²

5
- 20044363610
- + T helper cells and hindered by naturally occurring T regulatory cells
- + T helper cells and hindered by naturally occurring T regulatory cells. J Immunol. 2005;174:2591-2601.
- (2005) J Immunol , vol.174 , pp. 2591-2601
- Antony, P.A.¹ Piccirillo, C.A.² Akpinarli, A.³

6
- 0033571105
- + T cells: A common basis between tumor immunity and autoimmunity
- + T cells: a common basis between tumor immunity and autoimmunity. J Immunol. 1999;163:5211-5218.
- (1999) J Immunol , vol.163 , pp. 5211-5218
- Shimizu, J.¹ Yamazaki, S.² Sakaguchi, S.³

7
- 2442637772
- + T cell suppressor function
- + T cell suppressor function. J Immunol. 2004;172:6519-6523.
- (2004) J Immunol , vol.172 , pp. 6519-6523
- Thornton, A.M.¹ Donovan, E.E.² Piccirillo, C.A.³ Shevach, E.M.⁴

8
- 0037120053
- Interleukin 2 signaling is required for CD4(+) regulatory T cell function
- Furtado GC, Curotto de Lafaille MA, Kutchukhidze N, Lafaille JJ. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med. 2002;196:851-857.
- (2002) J Exp Med , vol.196 , pp. 851-857
- Furtado, G.C.¹ Curotto De Lafaille, M.A.² Kutchukhidze, N.³ Lafaille, J.J.⁴

9
- 0035806244
- Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood
- Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med. 2001;193:1303-1310.
- (2001) J Exp Med , vol.193 , pp. 1303-1310
- Dieckmann, D.¹ Plottner, H.² Berchtold, S.³ Berger, T.⁴ Schuler, G.⁵

10
- 0035806290
- Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood
- Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001;193:1285-1294.
- (2001) J Exp Med , vol.193 , pp. 1285-1294
- Jonuleit, H.¹ Schmitt, E.² Stassen, M.³ Tuettenberg, A.⁴ Knop, J.⁵ Enk, A.H.⁶

11
- 0035413350
- high regulatory cells in human peripheral blood
- high regulatory cells in human peripheral blood. J Immunol. 2001;167:1245-1253.
- (2001) J Immunol , vol.167 , pp. 1245-1253
- Baecher-Allan, C.¹ Brown, J.A.² Freeman, G.J.³ Hafler, D.A.⁴

12
- 0034679560
- Immunologic self-tolerance maintained by CD25(+) CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
- Takahashi T, Tagami T, Yamazaki S, et al. Immunologic self-tolerance maintained by CD25(+) CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000;192:303-310.
- (2000) J Exp Med , vol.192 , pp. 303-310
- Takahashi, T.¹ Tagami, T.² Yamazaki, S.³

13
- 1242295285
- + regulatory T cells
- + regulatory T cells. Semin Immunol. 2004;16:89-98.
- (2004) Semin Immunol , vol.16 , pp. 89-98
- Baecher-Allan, C.¹ Viglietta, V.² Hafler, D.A.³

14
- 0347785480
- Control of regulatory T cell development by the transcription factor Foxp3
- Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-1061.
- (2003) Science , vol.299 , pp. 1057-1061
- Hori, S.¹ Nomura, T.² Sakaguchi, S.³

15
- 15244354286
- Regulatory T cell lineage specification by the forkhead transcription factor foxp3
- Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005;22:329-341.
- (2005) Immunity , vol.22 , pp. 329-341
- Fontenot, J.D.¹ Rasmussen, J.P.² Williams, L.M.³ Dooley, J.L.⁴ Farr, A.G.⁵ Rudensky, A.Y.⁶

16
- 8344275995
- + regulatory T cells
- + regulatory T cells. Int Immunol. 2004;16:1643-1656.
- (2004) Int Immunol , vol.16 , pp. 1643-1656
- Yagi, H.¹ Nomura, T.² Nakamura, K.³

17
- 0346024131
- Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR
- Aerts JL, Gonzales MI, Topalian SL. Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR. Biotechniques. 2004;36:84-86, 88, 90-91.
- (2004) Biotechniques , vol.36 , pp. 84-86
- Aerts, J.L.¹ Gonzales, M.I.² Topalian, S.L.³

18
- 0343879405
- Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene
- U S A
- Depper JM, Leonard WJ, Drogula C, Kronke M, Waldmann TA, Greene WC. Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci U S A. 1985;82:4230-4234.
- (1985) Proc Natl Acad Sci , vol.82 , pp. 4230-4234
- Depper, J.M.¹ Leonard, W.J.² Drogula, C.³ Kronke, M.⁴ Waldmann, T.A.⁵ Greene, W.C.⁶

19
- 22344432319
- Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia
- Ruprecht CR, Gattorno M, Ferlito F, et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med. 2005;201:1793-1803.
- (2005) J Exp Med , vol.201 , pp. 1793-1803
- Ruprecht, C.R.¹ Gattorno, M.² Ferlito, F.³

20
- 0030691757
- + T cells
- + T cells. J Exp Med. 1997;186:1407-1418.
- (1997) J Exp Med , vol.186 , pp. 1407-1418
- Hamann, D.¹ Baars, P.A.² Rep, M.H.³

21
- 0026537863
- + lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo
- + lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur J Immunol. 1992;22:993-999.
- (1992) Eur J Immunol , vol.22 , pp. 993-999
- De Jong, R.¹ Brouwer, M.² Hooibrink, B.³ Van Der Pouw-Kraan, T.⁴ Miedema, F.⁵ Van Lier, R.A.⁶

22
- 16844363097
- A well adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor Foxp3
- Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol. 2005;6:331-337.
- (2005) Nat Immunol , vol.6 , pp. 331-337
- Fontenot, J.D.¹ Rudensky, A.Y.²

23
- 0348047537
- The main function of IL-2 is to promote the development of T regulatory cells
- Malek TR. The main function of IL-2 is to promote the development of T regulatory cells. J Leukoc Biol. 2003;74:961-965.
- (2003) J Leukoc Biol , vol.74 , pp. 961-965
- Malek, T.R.¹

24
- 15444374646
- + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
- + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med. 2005;201:723-735.
- (2005) J Exp Med , vol.201 , pp. 723-735
- Setoguchi, R.¹ Hori, S.² Takahashi, T.³ Sakaguchi, S.⁴

25
- 18144396195
- + regulatory T cells suppress effector T cell proliferation
- + regulatory T cells suppress effector T cell proliferation. Clin Immunol. 2005;115:3-9.
- (2005) Clin Immunol , vol.115 , pp. 3-9
- Earle, K.E.¹ Tang, Q.² Zhou, X.³

26
- 17144374934
- Regulatory T-cell therapy: Is it ready for the clinic?
- Bluestone JA. Regulatory T-cell therapy: is it ready for the clinic? Nat Rev Immunol. 2005;5:343-349.
- (2005) Nat Rev Immunol , vol.5 , pp. 343-349
- Bluestone, J.A.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.